Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effect of IFN-$\beta$, on the Antitumor Activity of Celecoxib in U87 Glioma Model

  • Kim, Eun-Kyoung (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital) ;
  • Chung, Dong-Sup (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Incheon St. Mary's Hospital) ;
  • Shin, Hye-Jin (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital) ;
  • Hong, Yong-Kil (Department of Neurosurgery, The Catholic University of Korea College of Medicine, Kangnam St. Mary's Hospital)
  • Published : 2009.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Interferon-$\beta$, (IFN-$\beta$) has been used in the treatment of cancers. Inhibition of the enzyme cyclooxygenase (COX) with celecoxib had a significantly suppressive effect on tumor growth, angiogenesis, and metastasis in a variety of tumors. The aim of this study was to elucidate the antiglioma effect of combined treatment with IFN-$\beta$ and celecoxib in U87 glioma model. Methods : The in vitro effects of IFN-$\beta$ (50-1,000 IU/mL) and celecoxib ($50-250\;{\mu}M$) alone or combination of both on the proliferation and apoptosis of U87 cells were tested using MTT assay, FACS analysis and DNA condensation. To determine the in vivo effect, nude mice bearing intracerebral U87 xenograft inoculation were treated with IFN-$\beta$ intraperitoneally ($2{\times}10^5\;IU/day$ for 15 days), celecoxib orally (5, 10 mg/kg) or their combination. Results : IFN-$\beta$ or celecoxib showed an inhibitory effect on the proliferation of U87 cells. When U87 cells were treated with IFN-$\beta$ and celecoxib combination, it seemed that IFN-$\beta$ interrupted the antiproliferative and apoptotic activity of celecoxib. No additive effect was observed on the survival of the tumor bearing mice by the combination of IFN-$\beta$ and celecoxib. Conclusion : These results suggest that IFN-$\beta$ seems to inhibit the antiglioma effect of celecoxib, therefore combination of IFN-$\beta$ and celecoxib may be undesirable in the treatment of glioma.

Keywords

References

  1. Cao B, Chen XP, Zhu P, Ding L, Guan J, Shi ZL : Inhibitory effect of interferon-$\alpha$-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice. World J Gastroenterol 14 : 6802-6807, 2008 https://doi.org/10.3748/wjg.14.6802
  2. Cao Y, Prescott SM : Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190 : 279-286, 2002 https://doi.org/10.1002/jcp.10068
  3. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, et al. : Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20 : 1635-1642, 2002 https://doi.org/10.1200/JCO.20.6.1635
  4. Chiu HW, Ho SY, Guo HR, Wang YJ : Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 5 : 472-483, 2009 https://doi.org/10.4161/auto.5.4.7759
  5. Deininger MH, Meyermann R, Trautmann K, Morgalla M, Duffner F, Grote EH, et al. : Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res 885 : 111-116, 2000 https://doi.org/10.1016/S0006-8993(00)02978-4
  6. Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, et al. : Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59 : 872-879, 1999
  7. Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, et al. : Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res 6 : 3354-3360, 2000
  8. Huang SF, Kim SJ, Lee AT, Karashima T, Bucana C, Kedar D, et al. : Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel. Cancer Res 62 : 5720-5726, 2002
  9. Joki T, Heese O, Nikas DC, Bello L, Zhang J, Kraeft SK, et al. : Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60 : 4926-4931, 2000
  10. Juang SH, Wei SJ, Hung YM, Hsu CY, Yang DM, Liu KJ, et al. : IFNbeta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J Interferon Cytokine Res 24 : 231-243, 2004 https://doi.org/10.1089/107999004323034105
  11. Kardosh A, Blumenthal M, Wang WJ, Chen TC, Sch$\ddot{o}$nthal AH : Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther 3 : 55-62, 2004
  12. Kornblith PK, Welch WC, Bradley MK : The future of therapy for glioblastoma. Surg Neurol 39 : 538-543, 1993 https://doi.org/10.1016/0090-3019(93)90041-X
  13. Krown SE : Interferons in malignancy : biological products or biological response modifiers? J Natl Cancer Inst 80 : 306-309, 1998
  14. Lee J, Jung HH, Im YH, Kim JH, Park JO, Kim K, et al. : Interferon-alpha resistance can be reversed by inhibition of IFN-alphainduced COX-2 expression potentially via STAT1 activation in A549 cells. Oncol Rep 15 : 1541-1549, 2006
  15. Ma Z, Qin H, Benveniste EN : Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta : critical role of STAT-1alpha. J Immunol 167 : 5150-5159, 2001 https://doi.org/10.4049/jimmunol.167.9.5150
  16. Mathieu V, De N$\acute{e}$ve N, Le Mercier M, Dewelle J, Gaussin JF, Dehoux M, et al. : Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia 10 : 1383-1392, 2008 https://doi.org/10.1593/neo.08928
  17. Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, et al. : Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Int J Oncol 29 : 625-635, 2006
  18. Nam DH, Park K, Park C, Im YH, Kim MH, Lee S, et al. : Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Oncol Rep 11 : 263-268, 2004
  19. Natsume A, Mizuno M, Ryuke Y, Yoshida J : Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Ther 6 : 1626-1633, 1999 https://doi.org/10.1038/sj.gt.3300990
  20. Ohno M, Natsume A, Fujii M, Ito M, Wakabayashi T : Interferonbeta, MCNU, and conventional radiotherapy for pediatric patients with brainstem glioma. Pediatr Blood Cancer 53 : 37-41, 2009 https://doi.org/10.1002/pbc.21987
  21. Park JA, Joe YA, Kim TG, Hong YK : Potentiation of antiglioma effect with combined temozolomide and interferon-beta. Oncol Rep 16 : 1253-1260, 2006
  22. Peres E, Wood GW, Poulik J, Baynes R, Sood S, Abidi MH, et al. : High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors. Neuropediatrics 39 : 151-156, 2008 https://doi.org/10.1055/s-0028-1093333
  23. Prayson RA, Castilla EA, Vogelbaum MA, Barnett GH : Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme. Ann Diagn Pathol 6 : 148-153, 2002 https://doi.org/10.1053/adpa.2002.33900
  24. Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attin$\acute{a}$ G, et al. : Phase II trial of temozolomide in children with recurrent high-grade glioma. J Neurooncol 77 : 89-94, 2006 https://doi.org/10.1007/s11060-005-9011-2
  25. Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF : Cyclooxygenase-2 expression in human gliomas : prognostic significance and molecular correlations. Cancer Res 61 : 4375-4381, 2001
  26. Taketo MM : Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90 : 1529-1536, 1998 https://doi.org/10.1093/jnci/90.20.1529
  27. Taketo MM : Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90 : 1609-1620, 1998 https://doi.org/10.1093/jnci/90.21.1609
  28. Thomas H, Balkwill FR : Effects of interferons and other cytokines on tumors in animals : a review. Pharmacol Ther 52 : 307-330, 1991 https://doi.org/10.1016/0163-7258(91)90030-P
  29. Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL, Xie K : Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res 64 : 2030-2038, 2004 https://doi.org/10.1158/0008-5472.CAN-03-1945